NEOG - Neogen Corporation
NASDAQ
->
Healthcare
->
Diagnostics & Research
Lansing,
United States
Type: Equity
NEOG price evolution
NEOG
| (in millions $) | 1 May 2024 | 31 Dec 2023 | 30 Oct 2023 | 1 Jul 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $161.44 | $205.76 | $178.83 | $163.24 |
| Short term investments | $7.01 | $24.5 | $60.42 | $82.33 |
| Net receivables | $173.59 | $150.5 | $137.67 | $153.25 |
| Inventory | $182.39 | $160.53 | $140.69 | $133.81 |
| Total current assets | $602.47 | $624.37 | $583.79 | $585.93 |
| Long term investments | ||||
| Property, plant & equipment | $287.58 | $259.31 | $235.59 | $198.75 |
| Goodwill & intangible assets | $3676.08 | $3702.73 | $3725.67 | $3742.6 |
| Total noncurrent assets | $3980.02 | $3978.04 | $3977.31 | $3968.5 |
| Total investments | $7.01 | $24.5 | $60.42 | $82.33 |
| Total assets | $4582.49 | $4602.41 | $4561.1 | $4554.43 |
| Current liabilities | ||||
| Accounts payable | $89.75 | $112.18 | $90.21 | $76.67 |
| Deferred revenue | $5.49 | $4.68 | $3.79 | $4.62 |
| Short long term debt | $2.52 | $2.57 | $2.64 | |
| Total current liabilities | $157.84 | $176.61 | $138.13 | $145.47 |
| Long term debt | $887.65 | $886.91 | $886.18 | $885.44 |
| Total noncurrent liabilities | $1278.47 | $1278.24 | $1276.8 | $1274.74 |
| Total debt | $890.17 | $889.48 | $888.82 | $885.44 |
| Total liabilities | $1436.32 | $1454.85 | $1414.93 | $1420.21 |
| Shareholders' equity | ||||
| Retained earnings | $561.03 | $563.06 | $566.54 | $565.04 |
| Other shareholder equity | -$29.47 | -$25.13 | -$26.5 | $3134.22 |
| Total shareholder equity | $3146.17 | $3147.57 | $3146.18 | $3134.22 |
| (in millions $) | 1 Jul 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $163.24 | $44.47 | $75.6 | $66.27 |
| Short term investments | $82.33 | $336.58 | $305.49 | $277.4 |
| Net receivables | $153.25 | $99.67 | $91.82 | $84.68 |
| Inventory | $133.81 | $122.31 | $100.7 | $95.05 |
| Total current assets | $585.93 | $626.8 | $591.45 | $537.41 |
| Long term investments | ||||
| Property, plant & equipment | $198.75 | $113.77 | $102.93 | $80.62 |
| Goodwill & intangible assets | $3742.6 | $250.21 | $223.79 | $176.92 |
| Total noncurrent assets | $3968.5 | $366.13 | $328.74 | $259.78 |
| Total investments | $82.33 | $336.58 | $305.49 | $277.4 |
| Total assets | $4554.43 | $992.93 | $920.19 | $797.18 |
| Current liabilities | ||||
| Accounts payable | $76.67 | $34.61 | $23.9 | $25.65 |
| Deferred revenue | $4.62 | $5.46 | ||
| Short long term debt | ||||
| Total current liabilities | $145.47 | $77.84 | $53.6 | $48.49 |
| Long term debt | $885.44 | |||
| Total noncurrent liabilities | $1274.74 | $27.71 | $26.22 | $23.52 |
| Total debt | $885.44 | |||
| Total liabilities | $1420.21 | $105.56 | $79.81 | $72 |
| Shareholders' equity | ||||
| Retained earnings | $565.04 | $587.91 | $539.6 | $478.72 |
| Other shareholder equity | $3134.22 | -$27.77 | -$11.38 | -$19.71 |
| Total shareholder equity | $3134.22 | $887.37 | $840.38 | $725.18 |
| (in millions $) | 1 May 2024 | 31 Dec 2023 | 30 Sep 2023 | 1 Jul 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $229.63 | $228.99 | $241.81 | |
| Cost of revenue | $112.86 | $112.23 | ||
| Gross Profit | $116.77 | $116.76 | $123.18 | |
| Operating activities | ||||
| Research & development | $5.76 | $6.72 | ||
| Selling, general & administrative | $96.55 | $90.9 | ||
| Total operating expenses | $102.31 | $97.63 | $99.76 | |
| Operating income | $14.46 | $19.14 | ||
| Income from continuing operations | ||||
| EBIT | $14.29 | $20.12 | ||
| Income tax expense | -$0.26 | $0.16 | $2.08 | |
| Interest expense | $18.03 | $18.46 | ||
| Net income | ||||
| Net income | -$3.49 | $1.5 | $5.57 | |
| Income (for common shares) | -$3.49 | $1.5 | ||
| (in millions $) | 1 Jul 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $822.45 | $527.16 | $468.46 | $418.17 |
| Cost of revenue | $284.15 | $253.4 | $221.89 | |
| Gross Profit | $405.95 | $243.01 | $215.06 | $196.28 |
| Operating activities | ||||
| Research & development | $17.05 | $16.25 | $14.75 | |
| Selling, general & administrative | $167.35 | $124.64 | $114.01 | |
| Total operating expenses | $368.44 | $184.4 | $140.89 | $128.76 |
| Operating income | $58.62 | $74.17 | $67.52 | |
| Income from continuing operations | ||||
| EBIT | $60.21 | $75.27 | $72.31 | |
| Income tax expense | $0.83 | $11.9 | $14.39 | $12.83 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$22.87 | $48.31 | $60.88 | $59.48 |
| Income (for common shares) | $48.31 | $60.88 | $59.48 | |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | -$2.02 | -$3.49 | $1.5 | $5.57 |
| Operating activities | ||||
| Depreciation | $29.65 | $29.47 | $28.73 | $28.44 |
| Business acquisitions & disposals | -$1.52 | |||
| Stock-based compensation | $3.68 | $3.51 | $2.64 | $2.87 |
| Total cash flows from operations | -$30.21 | $15.71 | $23.01 | $90.97 |
| Investing activities | ||||
| Capital expenditures | -$32.13 | -$24.39 | -$30.59 | -$25.36 |
| Investments | $17.49 | $35.92 | $21.91 | $33.75 |
| Total cash flows from investing | -$14.64 | $11.54 | -$8.68 | $6.88 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.3 | $0.08 | $1.06 | $0.25 |
| Net borrowings | -$0.06 | -$0.39 | -$19.28 | |
| Total cash flows from financing | $1.25 | -$0.31 | $1.06 | $0.25 |
| Effect of exchange rate | -$0.73 | -$0.01 | $0.2 | $3.23 |
| Change in cash and equivalents | -$44.33 | $26.93 | $15.59 | $96.11 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$22.87 | $48.31 | $60.88 | $59.48 |
| Operating activities | ||||
| Depreciation | $88.38 | $23.69 | $21.04 | $18.4 |
| Business acquisitions & disposals | $11.72 | -$38.74 | -$50.77 | -$13.16 |
| Stock-based compensation | $10.18 | $7.15 | $6.44 | $6.47 |
| Total cash flows from operations | $41.03 | $68.04 | $81.09 | $85.88 |
| Investing activities | ||||
| Capital expenditures | -$64.93 | -$24.43 | -$26.71 | -$24.05 |
| Investments | $254.25 | -$34.05 | -$28.08 | -$51.57 |
| Total cash flows from investing | $201.04 | -$97.23 | -$105.56 | -$88.78 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.2 | $7.93 | $34.63 | $29.41 |
| Net borrowings | -$119.28 | |||
| Total cash flows from financing | -$118.08 | $6.81 | $33.54 | $29.41 |
| Effect of exchange rate | -$1.92 | |||
| Change in cash and equivalents | $118.77 | -$31.13 | $9.33 | $24.58 |
News
Fundamentals
| Market cap | $2.67B |
|---|---|
| Enterprise value | $3.40B |
| Shares outstanding | 216.61M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.84 |
| Book/Share | 14.66 |
| Cash/Share | 0.75 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.45 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.82 |
| Quick ratio | 2.66 |